French drug manufacturer Valneva recently completed human trials for the first vaccine against the tick-borne illness — and it could be widely available within five years. Here’s more ...
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.
Sign up for our newsletter and stay up-to-date on the most important news and commentary!
By subscribing, you agree to receive emails from LifeZette.com, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement. You further agree that the use of reCAPTCHA is subject to the Google Privacy and Terms of Use.
Join the Discussion
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.